Lipocine (LPCN) Depreciation & Amortization (CF) (2012 - 2025)

Lipocine (LPCN) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $14123.0 in Q3 2025.

• Quarterly Depreciation & Amortization (CF) rose 65.94% year-over-year to $14123.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $45801.0 (up 11.42% YoY) and the FY2024 annual result came in at $41106.0, up 43.42% from the prior year.
• Depreciation & Amortization (CF) declined to $14123.0 in Q3 2025, from $16108.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $16108.0 in Q2 2025 to a low of $1719.0 in Q1 2022.
• A 4-year average of $8334.7 and a median of $8091.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 213.85% — and 2024, when it advanced 5.2%.
• Tracing LPCN's Depreciation & Amortization (CF) over 4 years: stood at $2578.0 in 2022, then soared by 210.43% to $8003.0 in 2023, then jumped by 94.56% to $15571.0 in 2024, then slipped by 9.3% to $14123.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $14123.0 (Q3 2025), $16108.0 (Q2 2025), and $15570.0 (Q1 2025), per Business Quant data.